rextol 4 µg cápsula mole
rafarm, s.a. - paricalcitol - cápsula mole - 4 µg - paricalcitol 0.004 mg - paricalcitol - genérico - duração do tratamento: longa duração
rextol 4 µg cápsula mole
rafarm, s.a. - paricalcitol - cápsula mole - 4 µg - paricalcitol 0.004 mg - paricalcitol - genérico - duração do tratamento: longa duração
rextol 1 µg cápsula mole
rafarm, s.a. - paricalcitol - cápsula mole - 1 µg - paricalcitol 0.001 mg - paricalcitol - genérico - duração do tratamento: longa duração
rextol 1 µg cápsula mole
rafarm, s.a. - paricalcitol - cápsula mole - 1 µg - paricalcitol 0.001 mg - paricalcitol - genérico - duração do tratamento: longa duração
binocrit
sandoz gmbh - epoetina alfa - anemia; kidney failure, chronic - preparações antianêmicas - treatment of symptomatic anaemia associated with chronic renal failure (crf) in adult and paediatric patients: , treatment of anaemia associated with chronic renal failure in paediatric and adult patients on haemodialysis and adult patients on peritoneal dialysis;, treatment of severe anaemia of renal origin accompanied by clinical symptoms in adult patients with renal insufficiency not yet undergoing dialysis;, treatment of anaemia and reduction of transfusion requirements in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e. cardiovascular pré-existente anemia no início da quimioterapia).
epoetin alfa hexal
hexal ag - epoetina alfa - anemia; kidney failure, chronic; cancer - preparações antianêmicas - treatment of symptomatic anaemia associated with chronic renal failure (crf) in adult and paediatric patients: , treatment of anaemia associated with chronic renal failure in paediatric and adult patients on haemodialysis and adult patients on peritoneal dialysis;, treatment of severe anaemia of renal origin accompanied by clinical symptoms in adult patients with renal insufficiency not yet undergoing dialysis. , o tratamento da anemia e redução de transfusão de requisitos em doentes adultos a receber quimioterapia para tumores sólidos, linfoma maligno ou mieloma múltiplo e em risco de transfusão de acordo com a avaliação do paciente estado geral (e. cardiovascular pré-existente anemia no início da quimioterapia).
renagel
sanofi b.v. - sevelamer - renal dialysis; hyperphosphatemia - todos os outros produtos terapêuticos - renagel is indicated for the control of hyperphosphataemia in adult patients receiving haemodialysis or peritoneal dialysis. renagel should be used within the context of a multiple therapeutic approach, which could include calcium supplements, 1,25 - dihydroxy vitamin d3 or one of its analogues to control the development of renal bone disease.
anaseptil
cosmed industria de cosmeticos e medicamentos s.a. - bacitracina zÍncica, oxido de zinco, perÓxido de zinco, sulfato de neomicina, sulfato de polimixina b - antisseptico
cefacimed
cimed industria s.a - cefalexina monoidratada - cefalosporinas
cefagel
multilab industria e comercio de produtos farmaceuticos ltda - cefalexina - cefalosporinas